MATERNUS-Kliniken-AG
XETRA:MAK

Watchlist Manager
MATERNUS-Kliniken-AG Logo
MATERNUS-Kliniken-AG
XETRA:MAK
Watchlist
Price: 1.02 EUR 7.94% Market Closed
Market Cap: 21.4m EUR

Wall Street
Price Targets

MAK Price Targets Summary
MATERNUS-Kliniken-AG

There are no price targets for MAK.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
MATERNUS-Kliniken-AG Competitors:
Price Targets
HEAL
Medikaloka Hermina Tbk PT
27% Upside
RYM
Ryman Healthcare Ltd
15% Upside
AGARWALEYE
Dr. Agarwal's Health Care Ltd
12% Upside
M12
M1 Kliniken AG
42% Upside
TRP
Aesthetic Connect PCL
19% Upside
USPH
US Physical Therapy Inc
35% Upside
ASTERDM
Aster DM Healthcare Ltd
29% Upside
300015
Aier Eye Hospital Group Co Ltd
34% Upside

Revenue
Forecast

Revenue Estimate
MATERNUS-Kliniken-AG

For the last 13 years the compound annual growth rate for MATERNUS-Kliniken-AG's revenue is 0%. The projected CAGR for the next 9 years is 1%.

0%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
MATERNUS-Kliniken-AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
MATERNUS-Kliniken-AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MAK's stock price target?
Not Available

MAK doesn't have any price targets made by Wall Street professionals.

What is MATERNUS-Kliniken-AG's Revenue forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for MATERNUS-Kliniken-AG's revenue is 0%. The projected CAGR for the next 9 years is 1%.

Back to Top